Marizyme (MRZM) Financial Statements

Marizyme's market cap is currently $132.00. The company's EPS TTM is $-0.337; its P/E ratio is -0.15; Marizyme is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.